A device that uses a single blood drop to determine whether a patient has a melanoma, and, possibly, at what stage, is being developed by an international research team that includes researchers from the Institute of Physics of the Czech Academy of Sciences led by the researcher Jakub Dostálek. As part of the VerSiLiB project, they are building a device capable of capturing and detecting even very small amounts of molecules produced by tumour cells, which can be used as biomarkers.
He likes to play with light, to put it bluntly. Jakub Dostálek, who is the latest acquisition of the Optics Division, focuses on investigating material properties and how they affect light. Or the other way round – how light affects material properties and the ways to control such properties using light. Having worked for over ten years abroad, he is now taking his first steps to return to Czechia.
